Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US8741335B2 · kind B2 · utility
32Cited by
104References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 13, 2006 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Feb 11, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Improved hemostatic agents take the form of granules or particles that can be used to stanch, seal, or stabilize a site of hemorrhage, including a noncompressible hemorrhage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.